Integrating Artificial Tear Formulations and Neuromodulation in the Management of Ocular Surface Disease

Complimentary

Live Virtual Webinar:
Tuesday, June 9, 2026, 1:00 PM ET/ 12:00 PM CT/ 11:00 AM MT/ 10:00 AM PT

Categories: , , , , , , , , , ,
Integrating Artificial Tear Formulations and Neuromodulation in the Management of Ocular Surface Disease

Take Me to the Event Registration

Program Description

This program will provide up-to-date, evidence-based information on pathophysiology, evaluation, artificial tear formulations, and neuromodulation in managing OSD.

Intended Audience

This activity is designed to meet the educational needs of ophthalmologists, optometrists, advanced practice providers (physician assistants and nurse practitioners), and nurses who manage patients with ocular surface disease (OSD).

Commercial Supporter

Supported by an unrestricted educational grant from Alcon Vision, LLC

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Integrate the evidence-based information on pathophysiology, risk factors, and evaluation of ocular surface disease.
  • Implement data on artificial tear formulations and neuromodulation in managing ocular surface disease.

Accredited Providers

Jointly Accredited by Amedco and MedNet

      

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco and MedNet. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation

Amedco designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

PAs may claim a maximum of 1.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit. 1.25 hours.

Optometrists Synchronous Virtual (Virtual Zoom)

This activity, COPE course (Pending), is accredited by COPE for continuing education for optometrists. COPE Activity ID# (Pending).

MedNet designates this activity for a maximum of 1.25 COPE credits.

Faculty

Ian Pitha, MD, PhD
Glaucoma Specialist
Associate Director of the Alan S. Crandall Center for Glaucoma Innovation at Moran Eye Center
University of Utah
Salt Lake City, Utah

Dr. Pitha’s speaker disclosures will be available prior to the commencement of the activity.

 

Stephen Pflugfelder, MD
Professor and James and Margaret Elkins Chair in Ophthalmology
Baylor College of Medicine
Houston, TX

Dr. Pflugfelder’s speaker disclosures will be available prior to the commencement of the activity.

Instructions

In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.

Related products